Fortress Biotech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Fortress Biotech generated cash of -$128,225,000, which is more than the previous year. Cash used in financing activities reached the amount of $32,738,999 last year. Net change in cash is therefore -$97,589,000.
Cash Flow
| 2014 | -16.33M | -23.27M | -10.15M |
|---|---|---|---|
| 2015 | -20.37M | 7.88M | 60.91M |
| 2016 | -45.81M | -6.06M | 41.98M |
| 2017 | -85.43M | -41.62M | 154.20M |
| 2018 | -98.84M | 18.82M | 50.64M |
| 2019 | -94.96M | 20.09M | 146.71M |
| 2020 | -83.68M | -7.16M | 172.41M |
| 2021 | -116.54M | 40.51M | 148.99M |
| 2022 | -179.40M | -22.92M | 75.31M |
| 2023 | -128.22M | -2.10M | 32.73M |
FBIOP Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 180.95M | 307.96M | 234.99M | 153.43M | 81.58M | 110.95M | 104.15M | 98.18M | 49.75M | 99.52M |
Operating activities | ||||||||||
Net income | -60.63M | -213.91M | -164.82M | -102.98M | -101.66M | -130.8M | -99.83M | -71.29M | -53.88M | -20.38M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 5.99M | 9.35M | 6.79M | 5.32M | 4.65M | 2.05M | 3.35M | 1.12M | 26K | 23K |
Stock-based compensation expense | 17.02M | 22.98M | 19.48M | 13.45M | 13.18M | 15.01M | 14.00M | 12.12M | 14.29M | 5.54M |
| Deferred income tax benefit | 17.02M | 22.98M | 19.48M | 13.45M | 13.18M | 15.01M | 14.00M | 12.12M | 14.29M | 5.54M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 12.52M | -5.38M | 768K | -5.85M | -8.14M | 2.26M | -5.92M | -1.83M | 0 | 0 |
Inventories | 3.95M | 1.74M | -8.45M | -547K | -179K | -507K | 32K | -203K | 0 | 0 |
Accounts payable | -24.38M | 8.34M | 43.30M | 6.52M | 1.94M | 4.66M | 9.89M | 5.39M | 5.88M | -849K |
Cash generated by operating activities | -128.22M | -179.40M | -116.54M | -83.68M | -94.96M | -98.84M | -85.43M | -45.81M | -20.37M | -16.33M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -5M | -52.60M | -56.09M | -181K | -79.94M | -23.27M |
Investments In Property Plant And Equipment | -63K | -3.05M | -16.34M | -7.16M | -9.39M | -9.35M | -5.44M | -10.50M | -11.98M | 0 |
Acquisitions Net | 0 | -20M | 56.86M | 0 | -1.20M | 2.27M | -19K | 4.45M | -11.69M | 0 |
Cash generated by investing activities | -2.10M | -22.92M | 40.51M | -7.16M | 20.09M | 18.82M | -41.62M | -6.06M | 7.88M | -23.27M |
Financing activities | ||||||||||
Common Stock Issued | 80.37M | 40.25M | 172.80M | 178.06M | 137.38M | 0 | 95.11M | 40.28M | 57.81M | 0 |
Payments for dividends | -8.76M | -8.78M | -8.78M | -6.75M | -2.55M | -2.34M | -299K | 0 | 0 | 0 |
Repurchases of common stock | -400K | 0 | 0 | -70K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -36.84M | 49.24M | -15.75M | -89.67M | 15M | -17.29M | 37.16M | -6.39M | 10M | 355K |
Cash used in financing activities | 32.73M | 75.31M | 148.99M | 172.41M | 146.71M | 50.64M | 154.20M | 41.98M | 60.91M | -10.15M |
Net Change In Cash | -97.58M | -127.01M | 72.96M | 81.56M | 71.85M | -29.37M | 27.14M | -9.88M | 48.42M | -49.76M |
Cash at end of period | 83.36M | 180.95M | 307.96M | 234.99M | 153.43M | 81.58M | 131.30M | 88.29M | 98.18M | 49.75M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |